| | Vaxcyte inks up to $1B deal for fill-finish at Thermo Fisher's N.C. facility (fiercepharma.com) |
| 2 points by randycupertino 1 day ago | past | 1 comment |
|
| | Stealth scores FDA approval for first Barth syndrome treatment (fiercepharma.com) |
| 1 point by gmays 10 days ago | past | discuss |
|
| | Amid restructuring, Novo Nordisk directs employees to return to office (fiercepharma.com) |
| 3 points by randycupertino 22 days ago | past | 1 comment |
|
| | Pfizer scores FDA nod for hemophilia B gene therapy, will charge $3.5M per dose (fiercepharma.com) |
| 2 points by Ozarkian 5 months ago | past | 1 comment |
|
| | J&J subsidiary floats $6.48B settlement to resolve claims products caused cancer (fiercepharma.com) |
| 1 point by randycupertino on May 1, 2024 | past | 1 comment |
|
| | Moderna's mRNA vaccine manufacturing operations reveal state of the company (fiercepharma.com) |
| 2 points by jseliger on Feb 23, 2024 | past | 1 comment |
|
| | Novo Nordisk, Eli Lilly face scrutiny from EU's drug regulator over GLP-1 safety (fiercepharma.com) |
| 2 points by sturza on Sept 18, 2023 | past |
|
| | Merck defeats insurers in $1.4B cyberattack appeal (fiercepharma.com) |
| 1 point by RyeCombinator on May 3, 2023 | past |
|
| | Zantac’s maker kept quiet about cancer risks for 40 years (fiercepharma.com) |
| 216 points by N_A_T_E on Feb 15, 2023 | past | 126 comments |
|
| | Pfizer eyes 400% price hike for Covid vaccine in private US market (fiercepharma.com) |
| 29 points by mfiguiere on Oct 21, 2022 | past | 11 comments |
|
| | Pharma Biogen vows to contest EMA (EU) rejection of Aduhelm (fiercepharma.com) |
| 1 point by tima101 on Dec 17, 2021 | past |
|
| | Side effects surface in 40% of patients on Biogen's Alzheimer's drug Aduhelm (fiercepharma.com) |
| 3 points by tima101 on Dec 17, 2021 | past | 3 comments |
|
| | Moderna reveals source of Covid-19 vaccine contamination (fiercepharma.com) |
| 4 points by AndrewBissell on Sept 1, 2021 | past |
|
| | Pfizer and BioNTech's new vaccine brand name, Comirnaty (2020) (fiercepharma.com) |
| 1 point by nanis on Aug 23, 2021 | past |
|
| | Fierce Pharma (fiercepharma.com) |
| 2 points by graderjs on Aug 18, 2021 | past |
|
| | Biogen, FDA walk back controversial Aduhelm label after weeks of criticism (fiercepharma.com) |
| 1 point by gmays on July 9, 2021 | past | 1 comment |
|
| | Pharma Biogen,FDA walk back controversial Aduhelm label after fierce criticism (fiercepharma.com) |
| 6 points by jk888 on July 8, 2021 | past | 1 comment |
|
| | KRAS drug gets early FDA approval winning a shot against 'undruggable' cancer (fiercepharma.com) |
| 1 point by gmays on June 1, 2021 | past |
|
| | AstraZeneca vaccine renamed 'Vaxzevria' in Europe (fiercepharma.com) |
| 4 points by mgerullis on March 31, 2021 | past |
|
| | Pharma execs upset by Trump's drug pricing executive orders (fiercepharma.com) |
| 2 points by markus_zhang on July 29, 2020 | past |
|
| | AstraZeneca confirms Russia vaccine deal days after Covid-19 hacking accusations (fiercepharma.com) |
| 2 points by aaavl2821 on July 20, 2020 | past |
|
| | AstraZeneca scores $1.2B from U.S., to deliver hundreds of millions of vaccines (fiercepharma.com) |
| 1 point by MKais on May 22, 2020 | past |
|
| | Head Of Operation Warp Speed 'confident' in Covid-19 vaccine by year's end (fiercepharma.com) |
| 2 points by koalala on May 16, 2020 | past |
|
| | Gilead asks FDA to rescind remdesivir orphan drug tag after public backlash (fiercepharma.com) |
| 1 point by sorokod on April 15, 2020 | past |
|
| | Novartis, Incyte prepare clinical trial Covid-19 cytokine storm therapy (fiercepharma.com) |
| 1 point by hprotagonist on April 3, 2020 | past |
|
| | Novartis/Mylan/Teva to supply millions of chloroquine pills to fight Covid-19 (fiercepharma.com) |
| 1 point by teddyvangogh on March 20, 2020 | past |
|
| | Big Pharma CEOs' Chinese names: Here's how they look and what they mean (fiercepharma.com) |
| 1 point by aaavl2821 on Oct 1, 2019 | past |
|
| | Roche fought through a bidding war for $4.8B gene therapy buyout (fiercepharma.com) |
| 1 point by aaavl2821 on March 8, 2019 | past |
|
| | Pharma reps now need $750 marketing licenses to beat the streets in Chicago (fiercepharma.com) |
| 1 point by _vvdf on Nov 21, 2016 | past |
|
| | Compounder targets Turing's now-pricey Daraprim with $1-per-pill alternative (fiercepharma.com) |
| 1 point by tshtf on Oct 22, 2015 | past |
|
|
| More |
